Guggenheim Capital LLC 10x Genomics, Inc. Transaction History

Guggenheim Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $147,839 - $250,236	6,059 New	6,059 $220,000
Q2 2022 Aug 15, 2022	BUY	$36.95 - $82.41 $19,177 - $42,770	519 Added 10.0%	5,710 $258,000
Q1 2022 May 16, 2022	SELL	$55.7 - $145.79 $19,216 - $50,297	-345 Reduced 6.23%	5,191 $395,000
Q4 2021 Feb 14, 2022	BUY	$135.05 - $182.59 $263,077 - $355,685	1,948 Added 54.29%	5,536 $825,000
Q3 2021 Nov 15, 2021	BUY	$145.58 - $192.14 $200,900 - $265,153	1,380 Added 62.5%	3,588 $523,000
Q2 2021 Aug 13, 2021	BUY	$134.22 - $202.37 $35,165 - $53,020	262 Added 13.46%	2,208 $432,000
Q1 2021 May 13, 2021	SELL	$140.25 - $196.86 $69,003 - $96,855	-492 Reduced 20.18%	1,946 $352,000
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $308,333 - $399,100	2,438 New	2,438 $345,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.